Common Contracts
4 similar Consultancy Agreement contracts
Consultancy Agreement between a patient advocate and a pharmaceutical companyConsultancy Agreement • November 18th, 2021
This is a reference agreement, specific for Consultancy Agreements, that should be adapted according to the needs of the users. It is based on the “Guiding Principles on Reasonable Agreements between Patient Advocates and Pharmaceutical Companies”, provided by the WECAN project on “Reasonable Legal Agreements between Patient Advocates and Pharmaceutical Companies”. For the most recent version and more information about the guiding principles, please visit www.wecanadvocate.eu/rapp
Consultancy Agreement between a patient advocate and a pharmaceutical companyConsultancy Agreement • June 18th, 2020
Reference agreement “Consultancy Agreement” version 1.2 (16 June 2020) This is a reference agreement, specific for Consultancy Agreements, that should be adapted according to the needs of the users. It is based on the “Guiding Principles on Reasonable Agreements between Patient Advocates and Pharmaceutical Companies”, provided by the WECAN project on “Reasonable Legal Agreements between Patient Advocates and Pharmaceutical Companies”. For the most recent version and more information about the guiding principles, please visit www.wecanadvocate.eu/rapp
Consultancy Agreement between a patient advocate and a pharmaceutical companyConsultancy Agreement • December 17th, 2019
Reference agreement “Consultancy Agreement” version 1.1 (1 December 2019) This is a reference agreement, specific for Consultancy Agreements, that should be adapted according to the needs of the users. It is based on the “Guiding Principles on Reasonable Agreements between Patient Advocates and Pharmaceutical Companies”, provided by the WECAN project on “Reasonable Legal Agreements between Patient Advocates and Pharmaceutical Companies”. For the most recent version and more information about the guiding principles, please visit www.wecanadvocate.eu/rapp
Consultancy Agreement between a patient advocate and a pharmaceutical companyConsultancy Agreement • December 17th, 2019
Reference agreement “Consultancy Agreement” version 1.1 (17 December 2019) This is a reference agreement, specific for Consultancy Agreements, that should be adapted according to the needs of the users. It is based on the “Guiding Principles on Reasonable Agreements between Patient Advocates and Pharmaceutical Companies”, provided by the WECAN project on “Reasonable Legal Agreements between Patient Advocates and Pharmaceutical Companies”. For the most recent version and more information about the guiding principles, please visit www.wecanadvocate.eu/rapp
